Risk factors for perforation in microbial corneal ulcers in north India

British Journal of Ophthalmology

Volumn 90, Issue 6, 2006, Pages 686-689

  Titiyal, J S ^a   Negi, Smita ^a,b   Anand, A ^a,c   Tandon, R ^a   Sharma, N ^a   Vajpayee, R B ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; NATAMYCIN; QUINOLONE DERIVATIVE; STEROID; TOBRAMYCIN SULFATE;

ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; ATOPIC KERATOCONJUNCTIVITIS; CONTROLLED STUDY; CORNEA PERFORATION; CORNEA ULCER; CORNEA VASCULARIZATION; DEMOGRAPHY; FALLING; FEMALE; HUMAN; INDIA; KERATITIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ACCIDENT; OPHTHALMOLOGY; PRIORITY JOURNAL; RISK FACTOR; THERAPY DELAY; TRICHIASIS; VERNAL CONJUNCTIVITIS; VISION TEST; VISUAL DISORDER;

ADULT; AGED; CASE-CONTROL STUDIES; CORNEAL ULCER; DEVELOPING COUNTRIES; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33744794282     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.079533     Document Type: Article

References (30)

1. Whitcher JP, Shrinivasan M. Corneal ulceration in the developing world-a silent epidemic. Br J Ophthalmol 1997;81:622-3.
2. Thylefors B, Negrel AD, Pararajasegaram R, et al. Global data on blindness. Bull World health Organ 1995;73:115-21.
3. Whitcher JP, Shrinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001;79:214-21.
4. Wong T, Ormonde S, Gamble G, et al. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003;87:1103-8.
5. Miedziak AI, Miller MR, Rapuano CJ, et al. Risk factors for microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999;106:1106-71.
6. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002;86:1211-15.
7. Kunimoto DY, Sharma S, Garg P, et al. Corneal ulceration in the elderly in Hyderabad, south India. Br J Ophthalmol 2000;84:54-9.
8. Schaefer F, Bruttin O, Zografos L, et al. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001;85:842-7.
9. Coster DJ, Badenoch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol 1987;71:96-101.
10. Vajpayee RB, Dada T, Saxena R, et al. Study of the first contact management profile of cases of infectious keratitis: a hospital-based study. Cornea 2000;19:52-6.
11. Musch DC, Sugar A, Meyer RF. Demographic and predisposing factors in corneal ulceration. Arch Ophthalmol 1983;101:1545-8.
12. Tuft SJ. Suppurative keratitis. Br J Ophthalmol 2003;87:127.
13. Bowman RJ, Faal H, Dolin P, et al. Non-trachomatous corneal opacities in the Gambia-aetiology and visual burden. Eye 2002;16:27-32.
14. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiologic diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997;81:965-71.
15. Courtright P, Lewellan S, Kanjaloti S. Traditional eye medicines use among patients with corneal disease in rural Malawi. Br J Ophthalmol 1994;78:810-2.
16. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing, (Document M100-S3, vol 3), Villanova, PA, 1991.
17. May CS. Case-control designs for clinical research in ophthalmology. Arch Ophthalmol 1998;116:661-4.
18. Poole TRG, Hunter DL, Maliwa EMK, et al. Aetiology of microbial keratitis in northern Tanzania. Br J Ophthalmol 2002;86:941-2.
19. Ormerod LD. Causes and management of bacterial keratitis in the elderly. Can J Ophthalmol 1989;24:112-6.
20. Upadhyay MP, Karmacharya PC, Koirala S, et al. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol 2001;65:388-92.
21. Cruz CS, Cohen CJ, Rapuano C, et al. Microbial keratitis resulting in loss of the eye. Ophthalmic Surg Laser 1998;29:803-7.
22. McLeod SD, LaBree LD, Tayyanipour R, et al. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 1995;102:1943-8.
23. Gangopadhyay N, Daniell M, Weih L, et al. Fluoroquinolone and fortified antibiotics in the treatment of bacterial corneal ulcers. Br J Ophthalmol 2000;84:378-84.
24. O'Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy or bacterial keratitis. Arch Ophthalmol 1995;113:1257-65.
25. The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomised, controlled trial with conventional dual therapy. Ophthalmology 1997;104:1902-9.
26. Kunimoto DY, Sharma S, Garg P, et al. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin emerging resistance. Cornea 1996;15:66-71.
27. Mallari PLT, McCarty DJ, Daniell M, et al. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001;131:131-3.
28. Pollock GA, McKelvie PA, McCarty DJ, et al. In vivo effects of fluoroquinolones on rabbit corneas. Clin Experiment Ophthalmol 2003;31:517-21.
29. Sendzik J, Shakibaei M, Schafer-Korting M, et al. Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 2005;212:24-36.
30. Satpathy G, Vishalakshi P. Ulcerative keratitis: microbial profile and sensitivity pattern-a five year study. Ann Ophthalmol 1995;27:301-6.